|
|
|
|
|
|
|
|
|
|
|
•
|
|
Press Announcement: Affymetrix launches Axiom myDesign Targeted Genotyping (TG) Arrays
|
|
|
|
|
SANTA CLARA, Calif., May 19, 2011—Affymetrix, Inc. (NASDAQ: AFFX) today launched new Axiom™ myDesign™ Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions. This latest advancement allows researchers to design custom arrays to genotype 1,500 to 2.6 million markers per sample and rapidly transition from genome-wide scans to specific disease analyses with different experimental approaches on the same platform. In addition to Axiom myDesign TG Arrays, Affymetrix released a new version of the Axiom™ Genomic Database containing 11 million variants, making it the industry’s largest supply of validated genomic markers.
|
|
|
•
|
|
Award Announcement: Affymetrix named Product Leader of the Year by Frost and Sullivan
|
|
|
|
|
MOUNTAIN VIEW, Calif. — March 17, 2011— Based on its recent analysis of the life science research tools market, Frost & Sullivan recognizes Affymetrix, Inc. with the 2011 North America Frost & Sullivan Product Leadership of the Year Award for its unwavering focus on enhancing its core microarray technology while remaining attentive to its customers’ demands.
|
|
|
•
|
|
Introducing the Odyssey Fc Imaging System
|
|
|
|
|
The Odyssey Fc Imager is the first CCD imager that offers excellent infrared (IR) fluorescent and chemiluminescent imaging performance in one system. The Odyssey Fc optical system combines solid-state laser diodes at 685 and 785 nm with a low-noise, CCD camera for detection of IR and chemiluminescent signals.
|
|
|
|
|
|
|